Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6,401,869
-
Total 13F shares
-
181,873
-
Share change
-
+89,419
-
Total reported value
-
$45,256
-
Price per share
-
$0.25
-
Number of holders
-
11
-
Value change
-
+$22,236
-
Number of buys
-
6
-
Number of sells
-
1
Institutional Holders of MAINZ BIOMED N.V. - Common Stock (MYNZ) as of Q3 2024
As of 30 Sep 2024,
MAINZ BIOMED N.V. - Common Stock (MYNZ) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
181,873 shares.
The largest 10 holders included
Vontobel Holding Ltd., NORTHERN TRUST CORP, Steward Partners Investment Advisory, LLC, TWO SIGMA SECURITIES, LLC, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, XTX Topco Ltd, Wealth Quarterback LLC, FMR LLC, and CITIGROUP INC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.